Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03913468 · ClinicalTrials.gov registry record
Outcomes of Septic Shock Patients Treated With a Metabolic Resuscitation Bundle Consisting of Intravenous Hydrocortisone, Ascorbic Acid and Thiamine.
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 206
- Enrollment target
NCT03913468 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 206 participants.
The verdict
NCT03913468 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 206 participants
- Enrollment target
Study Summary
This is a retrospective chart review that will measure the impact on outcomes in septic shock patients who were resuscitated with a novel combination of medicines called iHAT (intravenous hydrocortisone -ascorbic acid-thiamine). Septic shock patients treated with this combination of drugs over the past two years will be compared with similar, concurrent septic shock patients who were not treated with this drug given that adoption of this therapy has been variable.
Interventions
- DRUG Intravenous Ascorbic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2019-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03913468
The ClinicalTrials.gov registry entry for NCT03913468 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intravenous Ascorbic Acid is the first listed.
NCT03913468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03913468 about?
NCT03913468 is a clinical study titled "Outcomes of Septic Shock Patients Treated With a Metabolic Resuscitation Bundle Consisting of Intravenous Hydrocortisone, Ascorbic Acid and Thiamine.". This is a retrospective chart review that will measure the impact on outcomes in septic shock patients who were resuscitated with a novel combination of medicines called iHAT (intravenous hydrocortisone -ascorbic acid-thiamine). Septic shock patients treated with this combination of drugs over the p...
What is the current status of trial NCT03913468?
This trial is currently completed. The enrollment target is 206 participants. The study started on 2019-01-01. Estimated completion is 2019-12-01.
What interventions are being tested in trial NCT03913468?
The interventions under investigation include: Intravenous Ascorbic Acid (DRUG).
Who is sponsoring clinical trial NCT03913468?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.